Schizophrenia Clinical Trials

Showing 521-540 of 661 trials

A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

NCT01010776

The purpose of this study is to evaluate effectiveness, tolerability (how well a participant can stand a particular medicine or treatment), and safety of flexible-dose of paliperidone extended release (ER) in participants with schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self), previously taking risperidone (an antipsychotic), but who are not satisfied with their treatment.

Schizophrenia

Janssen-Cilag Farmaceutica Ltda.223 participantsStarted Feb 2008

Belo Horizonte, Brazil • Criciúma, Brazil • Curitiba, Brazil +7 more locations

COMPLETEDPHASE3

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

NCT00095524

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

Body Weight ChangeSchizophreniaSchizoaffective Disorder+1 more

Otsuka Pharmaceutical Development & Commercialization, Inc.300 participantsStarted Mar 2004

Little Rock, Arkansas, United States • Anaheim, California, United States • Cerritos, California, United States +29 more locations

A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Related Searches

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Effect on Cognitive Function of a Treatment With Aripiprazole

A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia

Risperidone Augmentation in Patients With Schizophrenia

Enhancing the Outcome of Skills Training for People With Schizophrenia

Bifeprunox Extension to Extension Study in Patients With Schizophrenia

Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia

Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Open-label Study of Curcumin C-3 Complex in Schizophrenia

Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia